rs2069845
|
|
|
0.010 |
GeneticVariation |
BEFREE |
However, the frequency of rs</span>2069845 variants was not significantly different between PCa, BPH and control groups.
|
30345492 |
2019 |
rs1800796
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated to assess the association between rs1800796 and prostate cancer susceptibility.
|
27706719 |
2016 |
rs1800796
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In conclusion, we suggest that the IL-6-572C>G (rs1800796) gene polymorphism influences the development of prostate cancer.
|
26535651 |
2015 |
rs1800795
|
|
|
0.070 |
GeneticVariation |
BEFREE |
SNPs at the CRP locus are not associated with PCa risk in this cohort, while the association between rs1800795 and PCa risk warrants further investigation.
|
19267250 |
2009 |
rs1800795
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Direct sequencing of the PCR amplicon from genomic DNA was used for genotyping rs1800795 in all subjects [age-matched controls (N = 140) and prostate cancer patients (N = 164)].
|
24446297 |
2014 |
rs1800795
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Nevertheless, in the subgroup analysis by ethnicity, we identified that <i>IL-6</i>-rs1800795 polymorphism was associated with an increased risk of PCa for Caucasian individuals in dominant model (MM + MW vs. WW: OR = 1.245, 95%CI = 1.176-1.318, <i>P</i> < 0.001).
|
30854108 |
2019 |
rs1800795
|
|
|
0.070 |
GeneticVariation |
BEFREE |
The C allele of rs1800795 was associated with PCa r</span>isk in the assessed population (OR (95% CI) = 1.45 (1.06-1.98)).
|
30345492 |
2019 |
rs1800795
|
|
|
0.070 |
GeneticVariation |
BEFREE |
The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression.
|
29848725 |
2018 |
rs1800795
|
|
|
0.070 |
GeneticVariation |
BEFREE |
We investigated the role of two functional polymorphisms, IL-6-174G>C (rs1800795) and IL-6-572C>G (rs1800796), in the development of prostate cancer.
|
26535651 |
2015 |
rs1800795
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Overall estimates revealed no significant relationship between IL-6 rs1800795 polymorphism and prostate cancer risk in total analysis, but a risk-increasing effect of the polymorphism was detected in African-American subgroup under CC versus GG and CC versus GG + GC contrasts (OR 3.43, 95% CI 1.01-11.71; OR 3.51, 95% CI 1.04-11.82) after subgroup analysis by ethnicity.IL-6 rs1800795 polymorphism may enhance the susceptibility to prostate cancer in African-American men.
|
28296724 |
2017 |